<?xml version="1.0" encoding="UTF-8"?>
<p>Kinetoplastid diseases (leishmaniasis, trypanosomiasis and Chagas disease) received €67 million, making it the largest disease area in terms of EU funding (
 <xref rid="t0005" ref-type="table">Table 1</xref>). One of the kinetoplastid diseases, leishmaniasis, received the most funding dedicated to a single disease, €20.5 million. With an EU contribution of €31 million to 10 projects, research on helminth diseases was the second largest funding area; around half of the projects (five projects, €9.3 million) targeted schistosomiasis. Some €30 million was allocated to 17 projects on bacterial diseases, with more than three-quarters of this funding (€22 million) being allocated to research on diarrhoeal diseases. Finally, almost €23 million was allocated to three cross-cutting research projects spanning more than one group of pathogens.
</p>
